The stock of MBAC Fertilizer Corp (CVE:MBC) hit a new 52-week low and has $0.90 target or 10.00% below today’s $1.00 share price. The 9 months bearish chart indicates high risk for the $1.83 million company. The 1-year low was reported on Nov, 14 by Barchart.com. If the $0.90 price target is reached, the company will be worth $183,000 less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 19,864 shares traded hands or 35.68% up from the average. MBAC Fertilizer Corp (CVE:MBC) has risen 6.00% since October 15, 2016 and is uptrending. It has outperformed by 1.02% the S&P500.
More notable recent MBAC Fertilizer Corp (CVE:MBC) news were published by: Marketwatch.com which released: “TSX Delisting Review – MBAC Fertilizer Corp. (symbol:MBC MBC.WT)” on April 06, 2016, also Marketwatch.com with their article: “TSX Delisting Review – MBAC Fertilizer Corp. (symbol:MBC and MBC.WT)” published on June 24, 2016, Reuters.com published: “BRIEF-MBAC Fertilizer announces court approval of Brazilian restructuring …” on September 07, 2016. More interesting news about MBAC Fertilizer Corp (CVE:MBC) were released by: Reuters.com and their article: “BRIEF-MBAC Fertilizer announces filing under companies’ creditors arrangem…” published on August 04, 2016 as well as Marketwired.com‘s news article titled: “MBAC Fertilizer Reports Q1, 2016 Results” with publication date: June 03, 2016.
MBAC Fertilizer Corp. is a Canada-based company, which is engaged in the mining, production and exploration of phosphate fertilizers in the Brazilian market. The company has a market cap of $1.83 million. The Firm operates the Itafos Arraias Single Super Phosphate Operations. It currently has negative earnings. The Company’s divisions include Operations, Development and Exploration, and Corporate.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.